Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quidelortho Corp (NQ: QDEL )

66.67 -0.18 (-0.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 432,030
Open 66.86
Bid (Size) 64.90 (1)
Ask (Size) 68.33 (1)
Prev. Close 66.85
Today's Range 64.73 - 67.35
52wk Range 57.54 - 102.00
Shares Outstanding 41,632,759
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
QuidelOrtho to Participate in the Evercore ISI Conference
From QuidelOrtho Corporation
Via Business Wire
Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report
QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm. 
Via Benzinga

Performance

YTD
-21.56%
-21.56%
1 Month
+8.23%
+8.23%
3 Month
-11.86%
-11.86%
6 Month
-22.80%
-22.80%
1 Year
-28.01%
-28.01%

More News

Read More
Analyst Expectations for QuidelOrtho's Future
Via Benzinga
QuidelOrtho Reports Third Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core Profitability: Analyst
Via Benzinga
Where QuidelOrtho Stands With Analysts
Via Benzinga
QuidelOrtho's Return on Invested Capital Overview
Via Benzinga
QuidelOrtho: Q1 Earnings Insights
Via Benzinga
Earnings Scheduled For November 1, 2023
Via Benzinga
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
Via Benzinga
Exposures COVID-19
QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
Analyst Is Frustrated By QuidelOrtho's Reduction In Guidance - Here's Why
Via Benzinga
QuidelOrtho Reports Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Report Second Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Market Mixes It Up With A Broad Rally
Via Talk Markets
QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference
From QuidelOrtho Corporation
Via Business Wire
Something Happened In Biotech Last Week
Via Talk Markets
QuidelOrtho Reports First Quarter 2023 Financial Results
From QuidelOrtho Corporation
Via Business Wire
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.